BioAtla Inc. Granted Continued Nasdaq Listing with Conditions; Must Meet Equity and Bid Price Requirements by Early 2026

Reuters
09/23
BioAtla Inc. Granted Continued Nasdaq Listing with Conditions; Must Meet Equity and Bid Price Requirements by Early 2026

BioAtla Inc. is undergoing an ongoing delisting process from The Nasdaq Stock Market due to not meeting specific minimum requirements. The company presented a compliance plan to Nasdaq's Hearing Panel on September 9, 2025, outlining steps to regain compliance. The Panel granted BioAtla's request for continued listing, contingent on meeting certain conditions. BioAtla has already applied to transfer to The Nasdaq Capital Market as of September 18, 2025. The company aims to meet the necessary stockholder equity and bid price criteria by December 31, 2025, and February 2, 2026, respectively.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioAtla Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-211305), on September 22, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10